Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001209191-22-018448

Options or other derivatives

  • Chief Executive Officer acquired 48,313 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bagai Shaun Chief Executive Officer 2022-03-10 Grant or award · Employee Stock Option (right to buy) +48,313 48,313 D
Loading xslF345X03/doc4.xml…